Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?

被引:16
作者
Belli, Martina [1 ,2 ]
Barone, Lucy [1 ]
Longo, Susanna [3 ]
Prandi, Francesca Romana [1 ,4 ]
Lecis, Dalgisio [1 ]
Mollace, Rocco [3 ,5 ]
Margonato, Davide [2 ]
Muscoli, Saverio [1 ]
Sergi, Domenico [1 ]
Federici, Massimo [3 ]
Barilla, Francesco [1 ]
机构
[1] Tor Vergata Univ, Dept Syst Med, Div Cardiol, I-00133 Rome, Italy
[2] Ist Sci San Raffaele, Cardiovasc Imaging Unit, I-20132 Milan, Italy
[3] Tor Vergata Univ, Dept Syst Med, I-00133 Rome, Italy
[4] Icahn Sch Med Mt Sinai, Mt Sinai Hosp, Div Cardiol, 1 Gustave L Levy Pl, New York, NY 10029 USA
[5] Humanitas Gavazzeni, Cardiovasc Dept, I-24125 Bergamo, Italy
关键词
gut microbiota; cardiovascular diseases; trimethylamine N-Oxide; heart failure; atherosclerosis; TRIMETHYLAMINE-N-OXIDE; CHRONIC HEART-FAILURE; CLOSTRIDIUM-DIFFICILE INFECTION; INTESTINAL MICROBIOTA; MYOCARDIAL-INFARCTION; RISK; INFLAMMATION; HEALTH; EPIDEMIOLOGY; HYPERTENSION;
D O I
10.3390/ijms241511971
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A great deal of evidence has revealed an important link between gut microbiota and the heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) disease, including heart failure (HF). In HF, splanchnic hypoperfusion causes intestinal ischemia resulting in the translocation of bacteria and their metabolites into the blood circulation. Among these metabolites, the most important is Trimethylamine N-Oxide (TMAO), which is responsible, through various mechanisms, for pathological processes in different organs and tissues. In this review, we summarise the complex interaction between gut microbiota and CV disease, particularly with respect to HF, and the possible strategies for influencing its composition and function. Finally, we highlight the potential role of TMAO as a novel prognostic marker and a new therapeutic target for HF.
引用
收藏
页数:13
相关论文
共 96 条
  • [11] Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery
    Chu, Derrick M.
    Ma, Jun
    Prince, Amanda L.
    Antony, Kathleen M.
    Seferovic, Maxim D.
    Aagaard, Kjersti M.
    [J]. NATURE MEDICINE, 2017, 23 (03) : 314 - 326
  • [12] Cimmino G, 2023, J CARDIOVASC MED, V24, pE156, DOI 10.2459/JCM.0000000000001450
  • [13] Selective intestinal decontamination in advanced chronic heart failure: a pilot trial
    Conraads, VM
    Jorens, PG
    De Clerck, LS
    Van Saene, HK
    Leven, MM
    Bosmans, JM
    Schuerwegh, A
    Bridts, CH
    Wuyts, F
    Stevens, WJ
    Anker, SD
    Rauchhaus, M
    Vrints, CJ
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (04) : 483 - 491
  • [14] Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
    Cui, Li
    Zhao, Tingting
    Hu, Haibing
    Zhang, Wen
    Hua, Xiuguo
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [15] A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
    Desai, Mahesh S.
    Seekatz, Anna M.
    Koropatkin, Nicole M.
    Kamada, Nobuhiko
    Hickey, Christina A.
    Wolter, Mathis
    Pudlo, Nicholas A.
    Kitamoto, Sho
    Terrapon, Nicolas
    Muller, Arnaud
    Young, Vincent B.
    Henrissat, Bernard
    Wilmes, Paul
    Stappenbeck, Thaddeus S.
    Nunez, Gabriel
    Martens, Eric C.
    [J]. CELL, 2016, 167 (05) : 1339 - +
  • [16] Trimethylamine N-Oxide is Associated with Heart Failure Risk in Patients with Preserved Ejection Fraction
    Dong, Zengxiang
    Zheng, Sijia
    Shen, Zhaoqian
    Luo, Yingchun
    Hai, Xin
    [J]. LABORATORY MEDICINE, 2021, 52 (04) : 346 - 351
  • [17] Redox Role of Lactobacillus casei Shirota Against the Cellular Damage Induced by 2,2'-Azobis (2-Amidinopropane) Dihydrochloride-Induced Oxidative and Inflammatory Stress in Enterocytes-Like Epithelial Cells
    Finamore, Alberto
    Ambra, Roberto
    Nobili, Fabio
    Garaguso, Ivana
    Raguzzini, Anna
    Serafini, Mauro
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [18] Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat
    Gan, Xiaohong Tracey
    Ettinger, Grace
    Huang, Cathy X.
    Burton, Jeremy P.
    Haist, James V.
    Rajapurohitam, Venkatesh
    Sidaway, James E.
    Martin, Glynn
    Gloor, Gregory B.
    Swann, Jonathan R.
    Reid, Gregor
    Karmazyn, Morris
    [J]. CIRCULATION-HEART FAILURE, 2014, 7 (03) : 491 - 499
  • [19] Metagenomic analysis of the human distal gut microbiome
    Gill, Steven R.
    Pop, Mihai
    DeBoy, Robert T.
    Eckburg, Paul B.
    Turnbaugh, Peter J.
    Samuel, Buck S.
    Gordon, Jeffrey I.
    Relman, David A.
    Fraser-Liggett, Claire M.
    Nelson, Karen E.
    [J]. SCIENCE, 2006, 312 (5778) : 1355 - 1359
  • [20] Human Genetics Shape the Gut Microbiome
    Goodrich, Julia K.
    Waters, Jillian L.
    Poole, Angela C.
    Sutter, Jessica L.
    Koren, Omry
    Blekhman, Ran
    Beaumont, Michelle
    Van Treuren, William
    Knight, Rob
    Bell, Jordana T.
    Spector, Timothy D.
    Clark, Andrew G.
    Ley, Ruth E.
    [J]. CELL, 2014, 159 (04) : 789 - 799